Outcomes of Treatment With Spesolimab in Patients With Moderate to Severe Hidradenitis Suppurativa
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled clinical trial
Br J Dermatol 2024 Apr 05;[EPub Ahead of Print], A Alavi, E Prens, AB Kimball, JW Frew, JG Krueger, S Mukhopadhyay, H Gao, U Ranganathan, NB Ivanoff, AC Hernandez Daly, CC ZouboulisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.